ANTX AN2 Therapeutics, Inc. logo

ANTX AN2 Therapeutics, Inc.

Healthcare
$4.73-2.47%ClosedMarket Cap: $129.6M

As of 2026-05-26

Analyst Consensus

Consensus

Hold

Target (Consensus)

$9.00

Target (Median)

$9.00

Target Range

$9.00 - $9.00

Upside from current price: 90.3%

Rating Distribution

0 Strong Buy1 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-05-14Leerink PartnersupgradeOutperformMarket Perform
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Wed Dec 31$-1.12$33.2M1
Thu Dec 31$-0.96$72.7M1
Fri Dec 31$-1.04$217.0M1
Sun Dec 31$-1.02$389.9M1